New hope for diabetes treatment with the discovery of an enzyme that blocks insulin production. Promising potential for targeted therapies. Breaking research by Case Western Reserve University and University Hospitals.
Researchers discover breakthrough in diabetes understanding, paving the way for new treatments. Study identifies enzyme linked to insulin function and potential target for medication development. Exciting progress in diabetes research.
Discover how the NEUROG3 gene revolutionizes diabetes treatment by unlocking the potential to produce more hormone-producing cells for transplantation - a game-changer for diabetes patients.
Promising results for semaglutide in landmark trial, potentially expanding its use beyond diabetes treatment. Findings could benefit obesity and cardiovascular disease patients.
Discover the groundbreaking advancements in diabetes research, education, and care highlighted in SDRI's 2022 annual report. Transforming lives through innovative therapies.
India's National Pharmaceutical Pricing Authority has extended price control regulations to include 23 more drugs for illnesses such as arthritis, tuberculosis and diabetes. Manufacturers must now review their pricing to ensure patients are not being overcharged. This move aims to make drugs more affordable for patients, with ceiling prices set for essential treatments. Manufacturers must also provide regulators with a full list of prices via the IPDMS, and display a price list at their business site for easy access.
Promising results for semaglutide in landmark trial, potentially expanding its use beyond diabetes treatment. Findings could benefit obesity and cardiovascular disease patients.